Hanmi Pharm will increase its value through the creation of innovative new drugs and substantial growth
Daewoong Pharmaceutical, joint research with AI company Oncocross to expand indications for new drugs
Ministry of Food and Drug Safety approved 4 clinical trials including ovarian cancer anticancer drugs
‘Calcium drugs’ utilizing osteoporosis prevention and treatment increase the risk of cardiovascular disease> News
Responsibility for illegal manufacturing of non-preservation group drugs… There can be no concealment
Signed a joint research agreement with YBiologics’ three major French pharmaceutical companies for immuno-anticancer drugs